It is increasing well known that an individual’s genetic makeup can exert a profound influence upon response to medications, via a range of mechanisms. The highly respected Mayo Clinic is now stepping up its investment in pharmacogenomics, with the advent of the Right10 project which will incorporate considerations of pharmacogenomics into medical records at the prestigious health care organisation.
Pharmacogenomics gaining traction
Aug 9, 2018